Tirzepatide and the new era of twincretins for diabetes Article Swipe
Tricia Tan
,
Bernard Khoo
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/s0140-6736(21)01390-8
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/s0140-6736(21)01390-8
Related Topics
Concepts
Medicine
Semaglutide
Type 2 diabetes
Diabetes mellitus
Internal medicine
Dulaglutide
Weight loss
Gastroenterology
Disease
Kidney disease
Adverse effect
Placebo
Liraglutide
Endocrinology
Obesity
Alternative medicine
Pathology
Metadata
- Type
- letter
- Language
- en
- Landing Page
- https://doi.org/10.1016/s0140-6736(21)01390-8
- OA Status
- green
- Cited By
- 6
- References
- 11
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3177123446
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3177123446Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/s0140-6736(21)01390-8Digital Object Identifier
- Title
-
Tirzepatide and the new era of twincretins for diabetesWork title
- Type
-
letterOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-06-27Full publication date if available
- Authors
-
Tricia Tan, Bernard KhooList of authors in order
- Landing page
-
https://doi.org/10.1016/s0140-6736(21)01390-8Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://hdl.handle.net/10044/1/91244Direct OA link when available
- Concepts
-
Medicine, Semaglutide, Type 2 diabetes, Diabetes mellitus, Internal medicine, Dulaglutide, Weight loss, Gastroenterology, Disease, Kidney disease, Adverse effect, Placebo, Liraglutide, Endocrinology, Obesity, Alternative medicine, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 1, 2023: 2, 2022: 2Per-year citation counts (last 5 years)
- References (count)
-
11Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3177123446 |
|---|---|
| doi | https://doi.org/10.1016/s0140-6736(21)01390-8 |
| ids.doi | https://doi.org/10.1016/s0140-6736(21)01390-8 |
| ids.mag | 3177123446 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/34186023 |
| ids.openalex | https://openalex.org/W3177123446 |
| fwci | 0.96066777 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D003920 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Diabetes Mellitus |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D005749 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Gastric Inhibitory Polypeptide |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000067757 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Glucagon-Like Peptide-1 Receptor |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D006801 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Humans |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D003920 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Diabetes Mellitus |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D005749 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Gastric Inhibitory Polypeptide |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D000067757 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Glucagon-Like Peptide-1 Receptor |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000098860 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Tirzepatide |
| type | letter |
| title | Tirzepatide and the new era of twincretins for diabetes |
| biblio.issue | 10295 |
| biblio.volume | 398 |
| biblio.last_page | 97 |
| biblio.first_page | 95 |
| topics[0].id | https://openalex.org/T10401 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2712 |
| topics[0].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[0].display_name | Diabetes Treatment and Management |
| topics[1].id | https://openalex.org/T12539 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9994999766349792 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2736 |
| topics[1].subfield.display_name | Pharmacology |
| topics[1].display_name | Pharmacology and Obesity Treatment |
| topics[2].id | https://openalex.org/T11064 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9861000180244446 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2705 |
| topics[2].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[2].display_name | Antiplatelet Therapy and Cardiovascular Diseases |
| is_xpac | False |
| apc_list.value | 6830 |
| apc_list.currency | USD |
| apc_list.value_usd | 6830 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8203167915344238 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2909862629 |
| concepts[1].level | 5 |
| concepts[1].score | 0.8104515075683594 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q27261089 |
| concepts[1].display_name | Semaglutide |
| concepts[2].id | https://openalex.org/C2777180221 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7741259336471558 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[2].display_name | Type 2 diabetes |
| concepts[3].id | https://openalex.org/C555293320 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5923490524291992 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[3].display_name | Diabetes mellitus |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5438370108604431 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C2779829264 |
| concepts[5].level | 5 |
| concepts[5].score | 0.5187435746192932 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q21011228 |
| concepts[5].display_name | Dulaglutide |
| concepts[6].id | https://openalex.org/C544821477 |
| concepts[6].level | 3 |
| concepts[6].score | 0.49217286705970764 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q718113 |
| concepts[6].display_name | Weight loss |
| concepts[7].id | https://openalex.org/C90924648 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4468207061290741 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[7].display_name | Gastroenterology |
| concepts[8].id | https://openalex.org/C2779134260 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4456261396408081 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[8].display_name | Disease |
| concepts[9].id | https://openalex.org/C2778653478 |
| concepts[9].level | 2 |
| concepts[9].score | 0.44186466932296753 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1054718 |
| concepts[9].display_name | Kidney disease |
| concepts[10].id | https://openalex.org/C197934379 |
| concepts[10].level | 2 |
| concepts[10].score | 0.43954458832740784 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[10].display_name | Adverse effect |
| concepts[11].id | https://openalex.org/C27081682 |
| concepts[11].level | 3 |
| concepts[11].score | 0.4380340576171875 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[11].display_name | Placebo |
| concepts[12].id | https://openalex.org/C2781308992 |
| concepts[12].level | 4 |
| concepts[12].score | 0.36678993701934814 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q2526479 |
| concepts[12].display_name | Liraglutide |
| concepts[13].id | https://openalex.org/C134018914 |
| concepts[13].level | 1 |
| concepts[13].score | 0.3069188594818115 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[13].display_name | Endocrinology |
| concepts[14].id | https://openalex.org/C511355011 |
| concepts[14].level | 2 |
| concepts[14].score | 0.3012635111808777 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12174 |
| concepts[14].display_name | Obesity |
| concepts[15].id | https://openalex.org/C204787440 |
| concepts[15].level | 2 |
| concepts[15].score | 0.10919922590255737 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[15].display_name | Alternative medicine |
| concepts[16].id | https://openalex.org/C142724271 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0958692729473114 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[16].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8203167915344238 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/semaglutide |
| keywords[1].score | 0.8104515075683594 |
| keywords[1].display_name | Semaglutide |
| keywords[2].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[2].score | 0.7741259336471558 |
| keywords[2].display_name | Type 2 diabetes |
| keywords[3].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[3].score | 0.5923490524291992 |
| keywords[3].display_name | Diabetes mellitus |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5438370108604431 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/dulaglutide |
| keywords[5].score | 0.5187435746192932 |
| keywords[5].display_name | Dulaglutide |
| keywords[6].id | https://openalex.org/keywords/weight-loss |
| keywords[6].score | 0.49217286705970764 |
| keywords[6].display_name | Weight loss |
| keywords[7].id | https://openalex.org/keywords/gastroenterology |
| keywords[7].score | 0.4468207061290741 |
| keywords[7].display_name | Gastroenterology |
| keywords[8].id | https://openalex.org/keywords/disease |
| keywords[8].score | 0.4456261396408081 |
| keywords[8].display_name | Disease |
| keywords[9].id | https://openalex.org/keywords/kidney-disease |
| keywords[9].score | 0.44186466932296753 |
| keywords[9].display_name | Kidney disease |
| keywords[10].id | https://openalex.org/keywords/adverse-effect |
| keywords[10].score | 0.43954458832740784 |
| keywords[10].display_name | Adverse effect |
| keywords[11].id | https://openalex.org/keywords/placebo |
| keywords[11].score | 0.4380340576171875 |
| keywords[11].display_name | Placebo |
| keywords[12].id | https://openalex.org/keywords/liraglutide |
| keywords[12].score | 0.36678993701934814 |
| keywords[12].display_name | Liraglutide |
| keywords[13].id | https://openalex.org/keywords/endocrinology |
| keywords[13].score | 0.3069188594818115 |
| keywords[13].display_name | Endocrinology |
| keywords[14].id | https://openalex.org/keywords/obesity |
| keywords[14].score | 0.3012635111808777 |
| keywords[14].display_name | Obesity |
| keywords[15].id | https://openalex.org/keywords/alternative-medicine |
| keywords[15].score | 0.10919922590255737 |
| keywords[15].display_name | Alternative medicine |
| keywords[16].id | https://openalex.org/keywords/pathology |
| keywords[16].score | 0.0958692729473114 |
| keywords[16].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1016/s0140-6736(21)01390-8 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S49861241 |
| locations[0].source.issn | 0140-6736, 1474-547X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0140-6736 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Lancet |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Lancet |
| locations[0].landing_page_url | https://doi.org/10.1016/s0140-6736(21)01390-8 |
| locations[1].id | pmid:34186023 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Lancet (London, England) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/34186023 |
| locations[2].id | pmh:oai:spiral.imperial.ac.uk:10044/1/91244 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401396 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Spiral (Imperial College London) |
| locations[2].source.host_organization | https://openalex.org/I47508984 |
| locations[2].source.host_organization_name | Imperial College London |
| locations[2].source.host_organization_lineage | https://openalex.org/I47508984 |
| locations[2].license | cc-by-nc-nd |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal Article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | 97 |
| locations[2].landing_page_url | http://hdl.handle.net/10044/1/91244 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5014892318 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5873-3432 |
| authorships[0].author.display_name | Tricia Tan |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2801748203, https://openalex.org/I47508984 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Campus, London W12 0HS, UK |
| authorships[0].institutions[0].id | https://openalex.org/I2801748203 |
| authorships[0].institutions[0].ror | https://ror.org/05jg8yp15 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I153355300, https://openalex.org/I2801748203 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | Hammersmith Hospital |
| authorships[0].institutions[1].id | https://openalex.org/I47508984 |
| authorships[0].institutions[1].ror | https://ror.org/041kmwe10 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I47508984 |
| authorships[0].institutions[1].country_code | GB |
| authorships[0].institutions[1].display_name | Imperial College London |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Tricia M-M Tan |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Campus, London W12 0HS, UK |
| authorships[1].author.id | https://openalex.org/A5001440165 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4223-9736 |
| authorships[1].author.display_name | Bernard Khoo |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2801138448, https://openalex.org/I45129253 |
| authorships[1].affiliations[0].raw_affiliation_string | Endocrinology, Division of Medicine, University College London, Royal Free Campus, London, UK |
| authorships[1].institutions[0].id | https://openalex.org/I2801138448 |
| authorships[1].institutions[0].ror | https://ror.org/01ge67z96 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I169248724, https://openalex.org/I2801138448 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | The Royal Free Hospital |
| authorships[1].institutions[1].id | https://openalex.org/I45129253 |
| authorships[1].institutions[1].ror | https://ror.org/02jx3x895 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[1].institutions[1].country_code | GB |
| authorships[1].institutions[1].display_name | University College London |
| authorships[1].author_position | last |
| authorships[1].raw_author_name | Bernard Khoo |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Endocrinology, Division of Medicine, University College London, Royal Free Campus, London, UK |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://hdl.handle.net/10044/1/91244 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Tirzepatide and the new era of twincretins for diabetes |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10401 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2712 |
| primary_topic.subfield.display_name | Endocrinology, Diabetes and Metabolism |
| primary_topic.display_name | Diabetes Treatment and Management |
| related_works | https://openalex.org/W4289779349, https://openalex.org/W2993091388, https://openalex.org/W4376641692, https://openalex.org/W3025705096, https://openalex.org/W3066769783, https://openalex.org/W4379233206, https://openalex.org/W2885624998, https://openalex.org/W2963614034, https://openalex.org/W2786247186, https://openalex.org/W2913046323 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:spiral.imperial.ac.uk:10044/1/91244 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306401396 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Spiral (Imperial College London) |
| best_oa_location.source.host_organization | https://openalex.org/I47508984 |
| best_oa_location.source.host_organization_name | Imperial College London |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I47508984 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Journal Article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | 97 |
| best_oa_location.landing_page_url | http://hdl.handle.net/10044/1/91244 |
| primary_location.id | doi:10.1016/s0140-6736(21)01390-8 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S49861241 |
| primary_location.source.issn | 0140-6736, 1474-547X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0140-6736 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Lancet |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Lancet |
| primary_location.landing_page_url | https://doi.org/10.1016/s0140-6736(21)01390-8 |
| publication_date | 2021-06-27 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W2968073288, https://openalex.org/W2572398654, https://openalex.org/W3026428376, https://openalex.org/W3139973230, https://openalex.org/W2895135221, https://openalex.org/W3177393241, https://openalex.org/W2951522032, https://openalex.org/W2911644854, https://openalex.org/W3045729180, https://openalex.org/W3011482816, https://openalex.org/W2985692253 |
| referenced_works_count | 11 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5014892318 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 2 |
| corresponding_institution_ids | https://openalex.org/I2801748203, https://openalex.org/I47508984 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.72219178 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |